Blue Cloud Softech Share Price Surges Amid AI-Focused Expansion

Blue Cloud Softech, a prominent small-cap IT stock, continued its upward momentum for a third straight session on Thursday, December 11, 2025. Shares climbed 2.39% to ₹25.64 during intraday trades, reflecting growing optimism among investors about the company’s future prospects.

Despite this short-term momentum, the stock has seen a decline of 11.5% in the past month and a 56.27% drop over the past year. However, long-term investors have witnessed remarkable gains, with the company delivering multibagger returns of 350% over the last five years.

Market Performance: Rally Amid Volatility

• The stock has surged nearly 22% over the past five sessions, demonstrating strong market traction.
• Short-term volatility continues due to recent broader market fluctuations, but investor interest remains fueled by strategic initiatives.

Main News: Fundraising and Strategic Growth

Blue Cloud Softech’s recent rally is closely linked to its fundraising plans and AI-driven growth strategy:

• The company received in-principle approval from BSE to issue 31.68 crore equity shares at ₹23.06 each via preferential allotment.
• The proceeds will support the acquisition of M/s AIS Anywhere, with 14.1 crore shares allocated to Mrs Janaki Yarlagadda and 17.57 crore shares to M/s Siraj Holdings LLC.
• The board is scheduled to finalise allotment on December 10, 2025, with a listing application required within 20 days post-issuance.

This strategic fundraising strengthens Blue Cloud’s financial flexibility and positions the company to accelerate its global expansion.

Company Expansion: Scaling AI-Driven Platforms

Blue Cloud Softech is targeting a $957.3-billion market across 56 Commonwealth countries, focusing on its AI-powered healthcare platforms:

• BluBio: Biobanking and diagnostics
• BluHealth: Digital health solutions
• Bioster: Environmental safety and compliance

Partnerships with the Commonwealth Medical Association and the Indian Medical Association, representing 1.5 million healthcare professionals, are expected to boost adoption and streamline regulatory processes.

Additionally, the company secured a ₹110.8-crore contract from US-based Stratos Forge Inc for Data Annotation and AI Training Services. Blue Cloud has evolved its data annotation capabilities from manual labelling to automation-driven processing for advanced formats like 3D LiDAR, semantic text datasets, and high-resolution imaging.

Q2 FY25 Financial Snapshot

Blue Cloud Softech posted steady quarterly growth, reflecting its robust operational performance:

• Net Profit: ₹15 crore (up from ₹11 crore YoY)
• Operating Revenue: ₹253 crore (up from ₹235 crore YoY, +7.6%)

This performance underscores the company’s consistent focus on scaling its AI solutions and capturing global opportunities.

Summary

Blue Cloud Softech’s recent share price surge reflects its robust growth and strategic focus on AI-driven IT solutions. With successful fundraising, global expansion initiatives, and steady quarterly performance, the company continues to showcase its potential as a promising small-cap multibagger IT stock.

Investors are watching closely as Blue Cloud leverages its AI platforms and healthcare partnerships to tap into a vast, underserved global market.